Risk of herpes zoster in adults immunized with varicella vaccine.

The Journal of Infectious Diseases
Sophie HambletonA A Gershon

Abstract

A program of routine varicella vaccination of children 12-18 months of age, begun in the United States in 1995, has been very successful in reducing the incidence of varicella. Varicella-zoster virus (VZV), in both wild-type and live attenuated forms, is notable for its ability to produce latent infection of sensory neurons from which it can later reactivate to cause herpes zoster (HZ). Therefore, the effects of vaccination on this secondary VZV-related disease are important to consider; in practice, however, such studies are complicated by the typically long delay between acquisition of the virus and its reactivation. Studies of immunocompromised children have shown that vaccination is relatively protective against HZ in this highly vulnerable group. We now present long-term follow-up data on a group of individuals who received varicella vaccine as healthy young adults 10-26 years ago and who have been followed prospectively by means of active surveillance. Among some 2000 person-years of follow-up, 2 cases of HZ have occurred, for a rate of 1.00 case/1000 person-years. Overall, the incidence of HZ in this cohort, therefore, is similar to published data for the US population in the prevaccine era.

References

Sep 1, 1989·The Journal of Infectious Diseases·M R HammerschlagL D Gelb
Jul 20, 1984·JAMA : the Journal of the American Medical Association·A A GershonA Farrara
Aug 7, 1995·Archives of Internal Medicine·J G DonahueR Platt
Dec 1, 2000·The Pediatric Infectious Disease Journal·P LaRussaA A Gershon
Dec 15, 2000·Vaccine·R G SharrarA A Gershon
Mar 29, 2001·The New England Journal of Medicine·M VázquezE D Shapiro
Feb 7, 2002·JAMA : the Journal of the American Medical Association·Jane F SewardMelinda Wharton
Feb 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Krow AmpofoAnne Gershon
Feb 19, 2004·JAMA : the Journal of the American Medical Association·Marietta VázquezEugene D Shapiro
Aug 12, 2004·JAMA : the Journal of the American Medical Association·Jane F SewardAisha O Jumaan
Feb 4, 2005·The New England Journal of Medicine·Huong Q NguyenJane F Seward
Jun 3, 2005·The New England Journal of Medicine·M N OxmanUNKNOWN Shingles Prevention Study Group
Jul 30, 2005·Journal of General Internal Medicine·Ralph P InsingaAlexander A Nikas
Aug 18, 2005·JAMA : the Journal of the American Medical Association·Fangjun ZhouAbigail Shefer

❮ Previous
Next ❯

Citations

Dec 12, 2001·Primary Care·A L Campbell, K A Bryant
Aug 4, 2012·British Medical Bulletin·Andrew Flatt, Judy Breuer
Jun 8, 2012·Journal of Virology·Anca SelariuHua Zhu
May 30, 2009·BMC Medicine·Paolo BonanniPeter Wutzler
Feb 11, 2016·Enfermedades infecciosas y microbiología clínica·Luis García-ComasDolores Barranco Ordóñez
Apr 25, 2013·The Journal of Allergy and Clinical Immunology·David H Dreyfus
Feb 15, 2011·Maturitas·Pierre Olivier LangWayne A Mitchell
Mar 6, 2016·Vaccine·Tetsushi YoshikawaMasahiro Ohashi
Jan 16, 2013·Pediatric Annals·Trinidad Hasbún, Sarah L Chamlin
Apr 2, 2009·Dermatologic Therapy·Rosella CreedParisa Ravanfar
Jan 22, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V PapaevangelouJ Breuer
Jun 24, 2017·Expert Review of Vaccines·Peter WutzlerGiacomo Casabona
Jun 24, 2014·The Cochrane Database of Systematic Reviews·Kristine MacartneyPeter McIntyre
Oct 5, 2013·Clinical Microbiology Reviews·Anne A Gershon, Michael D Gershon
Jul 19, 2013·The Korean Journal of Pain·Kyung Hoon Kim
Jun 23, 2018·BMJ Case Reports·Karthik DarmasseelaneTatiana Rjabova
May 3, 2008·The Journal of Infectious Diseases·Anne A GershonMichael D Gershon
Apr 18, 2018·Clinical and Experimental Reproductive Medicine·Ju-Eun JeongKyu-Sup Lee
Mar 13, 2019·Frontiers in Oncology·Dwain G van ZylHenri-Jacques Delecluse

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.